Item 7.01. Regulation FD Disclosure

On May 29, 2012, Protalix BioTherapeutics, Inc. issued a press release announcing that senior management will present at three upcoming conferences. Details regarding the conferences are as follows:

Jefferies 2012 Global Healthcare Conference Presenter: Mr. Yossi Maimon, Chief Financial Officer

Corporate Presentation
Monday, June 4, 2012 at 1:30 PM EDT
New York, NY
A webcast of this presentation will be available at www.protalix.com on the event calendar page and a replay will be archived and available after the conference for 30 days.

2012 BIO International Convention
Presenter: Dr. David Aviezer, President and Chief Executive Officer

Session titled, "Neither Beast nor Bird: Addressing Biomanufacturing Challenges with New Expression Systems."
Tuesday, June 19, 2012 at 10:00 AM EDT
Room 258B of the Boston Convention & Exhibition Center, MA

Corporate Presentation
Tuesday, June 19, 2012 at 3:45 PM EDT

Room 104A of the Boston Convention & Exhibition Center, MA

Wells Fargo Securities Research & Economics 2012 Healthcare Conference Presenter: Dr. David Aviezer, President and Chief Executive Officer

Corporate Presentation

Wednesday, June 20, 2012 at 9:30 AM EDT
InterContinental Boston, Boston, MA
A webcast of this presentation will be available at www.protalix.com on the event calendar page and a replay will be archived and available after the conference for 30 days.

A copy of the press release is furnished as Exhibit 99.1.

The information contained in Item 7.01 of this report and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.